Ventral Hernia Treatment Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers

What industry-specific factors are fueling the growth of the ventral hernia treatment market?
The increasing rates of obesity are expected to accelerate the growth of the ventral hernia treatment market. Obesity is a medical condition characterized by excessive body fat that significantly affects an individual's health. Factors contributing to the rising prevalence of obesity include poor dietary habits, sedentary lifestyles, genetics, lack of physical activity, environmental influences, and emotional stress. Ventral hernia treatments benefit obese patients by addressing complications arising from excess weight, helping to reduce strain on the abdominal wall, decrease the risk of hernia recurrence, and strengthen the abdomen, which is crucial for promoting mobility and encouraging healthier lifestyle choices in obese individuals. For example, in March 2024, the World Health Organization (WHO) reported that roughly one in eight people worldwide were dealing with obesity, including 2.5 billion overweight adults, of whom 890 million were obese. Among adults, 43% were overweight, and 16% were classified as obese. Furthermore, 37 million children under the age of 5 were classified as overweight. Thus, the increasing prevalence of obesity is driving the ventral hernia treatment market.

Get Your Ventral Hernia Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/ventral-hernia-treatment-global-market-report

What Is the projected market size and growth rate for the ventral hernia treatment market?
The ventral hernia treatment market has grown substantially in recent years. It is forecasted to rise from $4.87 billion in 2024 to $5.23 billion in 2025, achieving a CAGR of 7.5%. The market's growth has been fueled by the increasing rates of obesity, higher awareness about ventral hernias, an aging population, rising disposable incomes, and growing demand for minimally invasive surgical procedures.

The ventral hernia treatment market is projected to see strong growth, reaching $6.90 billion by 2029, at a CAGR of 7.2%. Growth drivers include a rising demand for outpatient procedures, increasing healthcare expenditures, government initiatives to enhance treatment access, a growing need for hernia repair surgeries, and increased investments in research and development. Major trends in the market include advancements in hernia repair devices, the use of bioabsorbable materials, strategic collaborations, robotic-assisted surgery technologies, and the rise of remote monitoring solutions.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21315&type=smp

What new trends are reshaping the ventral hernia treatment market and its opportunities?
In the ventral hernia treatment market, major companies are advancing laparoscopic and open hernia mesh fixation devices to improve surgical outcomes, reduce complications, and enhance patient recovery. For instance, TELA Bio Inc., a US-based medical technology company, launched its LIQUIFIX FIX8 laparoscopic and LIQUIFIX Precision open hernia mesh fixation devices in March 2024. These devices use liquid anchors to securely affix mesh without penetrating tissue, which reduces trauma and lowers the risk of complications. The devices cater to both minimally invasive and open hernia repairs, offering a safer, more precise solution to hernia surgeries with a focus on minimizing vascular or nerve injury.

What major market segments define the scope and growth of the ventral hernia treatment market?
The ventral hernia treatment market covered in this report is segmented -

1) By Type: Epigastric (Stomach Area) Hernia, Umbilical (Belly Button) Hernia, Incisional Hernia
2) By Diagnosis: Ultrasound, Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI)
3) By Surgery: Open Hernia Surgery, Laparoscopic Surgery, Robotic Hernia Surgery
4) By End Users: Hospitals, Ambulatory Surgical Centres, Clinics

Subsegments:
1) By Epigastric (Stomach Area) Hernia: Small Epigastric Hernia, Large Epigastric Hernia
2) By Umbilical (Belly Button) Hernia: Congenital Umbilical Hernia, Acquired Umbilical Hernia
3) By Incisional Hernia: Primary Incisional Hernia, Recurrent Incisional Hernia

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21315

Which region dominates the ventral hernia treatment market?
North America was the largest region in the ventral hernia treatment market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the ventral hernia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the ventral hernia treatment industry growth?
Major companies operating in the ventral hernia treatment market are Johnson And Johnson Services Inc., AbbVie, Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company (BD), Baxter International Inc., Braun Melsungen AG, Zimmer Biomet, Olympus Corporation, W.L. Gore and Associates Inc, STERIS Plc, Cook Medical Inc., KARL STORZ, Cooper University Health Care, Mölnlycke Health Care, Integra LifeSciences Holdings, ConMed Corporation, Aesculap Inc, Richard Wolf GmbH, Ethicon Inc, Tela Bio, Microline Surgical, Hernia Mesh S.R.L., Insightra Medical Inc, Advanced MedTech Solutions Pvt Ltd.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21315&type=smp

What Is Covered In The Ventral Hernia Treatment Global Market Report?

•Market Size Forecast: Examine the ventral hernia treatment market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the ventral hernia treatment market for a structured understanding.
•Key Players Overview: Analyze major players in the ventral hernia treatment market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the ventral hernia treatment market.
•Segment Contributions: Evaluate how different segments drive overall growth in the ventral hernia treatment market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the ventral hernia treatment market.
•Industry Challenges: Identify potential risks and obstacles affecting the ventral hernia treatment market.
•Competitive Landscape: Review strategic developments in the ventral hernia treatment market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.